Sectors

CURX
Curanex Pharmaceuticals Inc Common Stock
0.21
4 x 0.20
1 x 0.24
bid
ask
-
0.00
2.16%
20 @ 04:00 PM
0.22 +0.01 (3.39%)
Ytd-35.74%
1y-94.71%
0.20
day range
0.22
0.18
52 week range
9.18
Open0.22Prev Close0.22Low0.20High0.22Mkt Cap6.03M
Vol240.66KAvg Vol88.78KEPS-0.28P/E-0.76Forward P/EN/A
BetaN/AShort RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg0.24200-d Avg0.371yr Est0.00
Income Statement
Operating Expenses3.33M
Research and Development Expense2.59M
Selling, General and Administrative Expense731.84K
Operating Income-3.33M
Net Income-3.29M
Net Income Common Stock-3.29M
Net Income Common Stock (USD)-3.29M
Consolidated Income-3.29M
Earnings per Basic Share-0.12
Earnings per Basic Share (USD)-0.12
Earnings per Diluted Share-0.12
Earning Before Interest & Taxes (EBIT)-3.29M
Earning Before Interest & Taxes (USD)-3.29M
Weighted Average Shares28.36M
Weighted Average Shares Diluted28.36M
Balance Sheet
Cash and Equivalents2.94M
Cash and Equivalents (USD)2.94M
Current Assets4.79M
Property, Plant & Equipment Net280.94K
Total Assets5.07M
Debt Current94.41K
Total Debt276.36K
Current Liabilities104.31K
Debt Non-Current181.95K
Total Liabilities286.25K
Accumulated Retained Earnings (Deficit)-11.29M
Shareholders Equity4.79M
Shareholders Equity (USD)4.79M
Assets Non-Current280.94K
Total Debt (USD)276.36K
Liabilities Non-Current181.95K
Trade and Non-Trade Payables154.00
Cash Flow
Depreciation, Amortization & Accretion36.64K
Net Cash Flow / Change in Cash & Cash Equivalents-1.08M
Net Cash Flow from Operations-1.08M